INVESTMENT ADVISORY SERVICES INC /TX /ADV
Position in JNJ — Johnson & Johnson
CIK 925953
THE WOODLANDS, TX
Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$6,612,362
+$261,811 QoQ
Shares Held
26,036
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.26%
of 13F equity value
Holder Rank
#1,395
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INVESTMENT ADVISORY SERVICES INC /TX /ADV holds $16,555,030 across 7 Drug Manufacturers - General names. JNJ ranks #1 (39.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
26,036 | $6,612,362 | |
| 2 | ABBV |
AbbVie Inc.
|
24,722 | $6,221,044 | |
| 3 | AMGN |
Amgen Inc
|
5,246 | $1,899,681 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,465 | $959,252 | |
| 5 | LLY |
ELI LILLY & Co
|
296 | $355,031 | |
| 6 | PFE |
Pfizer Inc
|
12,058 | $290,356 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,720 | $217,304 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,612,362 | 26,036 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $6,350,551 | 25,980 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $5,482,726 | 26,493 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $4,994,843 | 26,938 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $4,151,286 | 27,177 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $4,457,281 | 26,877 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $3,928,457 | 27,164 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $4,461,997 | 27,533 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $4,420,901 | 30,247 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $5,041,040 | 31,867 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $5,246,401 | 33,472 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $5,631,141 | 36,155 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $5,985,699 | 36,163 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,397,720 | 34,824 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $6,122,689 | 34,660 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,654,543 | 34,614 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $6,146,816 | 34,628 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,207,303 | 35,024 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $5,993,608 | 35,036 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $5,578,048 | 34,539 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $5,667,056 | 34,400 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $5,540,562 | 35,205 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $5,282,709 | 35,483 | Shares | Sole | 2021-03-10 | |
| 2020-06-30 | $4,975,208 | 35,378 | Shares | Sole | 2021-03-10 | |
| 2020-03-31 | $4,612,104 | 35,172 | Shares | Sole | 2021-03-10 | |
| No filing history on record for this holder in this stock. | ||||||